Page 18 - Divi Lab News Today

Sensex Tumbles Over 400 Points, Nifty Settles Below 14,500 Tata Consumer Products dived nearly 5 per cent to top the losers list on the BSE, while pharma stocks such as Cipla, Dr Reddys and Divis Lab lost 1-3 per cent each Updated: May 04, 2021 3:40 pm IST Cipla, Dr Reddys, Divis Lab and Sun Pharma lost 1-3 per cent each on the BSE The benchmark indices tumbled nearly one per cent in the late-afternoon session to end near the lows of the day, amid heightened volatility. The BSE Sensex swun...

The Bank index was the top sectoral loser on the BSE, shedding over 2 per cent. The benchmark indices have slipped more than a per cent in the afternoon session to trade near the lows of the day, as fears surrounding the mounting Covid cases came back to haunt the market participants after a four-day rally. At 1:45 pm, the BSE Sensex was trading at 49,064.45, lower by 700.05 points or 1.33 per cent and the NSE Nifty was at 14,715.25, down 163.45 points or 1.30 per cent. The Bank index was the t...

Explore Now Nifty and Bank Nifty have failed to break past that gap down, which was created post the Monday selling and that has really hurt the sentiments for the indices, says the independent market expert Kunal Bothra. Excerpts from an interview: We had a scary Monday and since then we saw a steady rebound coming in. Is the rebound enough for us to not test Monday’s lows of 14,320? We saw more of a repel trade or a repair mode in the second half of the week. The Monday selloff put in quite...

LIC betting on old economy stocks Buys shares worth ₹3,000 crore in at least 15 companies The biggest domestic institutional investor LIC has upped holdings in at least 15 companies by buying shares worth ₹3,000 crore during January-March quarter even as markets rose nearly 4 per cent. LIC has hiked stakes in old economy sector companies such as those involved in manufacture of cement, auto ancillaries, chemicals, energy and paints. However, it also appears to have booked profits partly in ...

Explore Now Among largecaps, HCL Technology makes sense valuation wise and there are a lot of opportunities in midcaps also, says Quantum Securities. From a valuation standpoint, how does IT stack up and would you be also looking at a lot of the midcap IT names? Neeraj Dewan: We were looking at midcap IT but after the correction in largecap IT, it makes sense to invest more in IT largecaps. The last quarter’s numbers were pretty good and even the deal wins are good. Stocks like TCS, HCL Tec...

NEW DELHI: Niftys consolidation run continued to the third consecutive day as the headline index formed a bearish candle on the daily chart. The 50-pack bluechips underperformed the broader market as the rally continued in the midcap and smallcap space. Ajit Mishra, VP - Research, Religare Broking said, "In absence of any major trigger, we may see further consolidation in markets. Meanwhile, the focus should be on position management. Nifty has the next major support around the 14,850-14,950 zo...

The only circumstance in which this market can see a pullback is if inflation comes back strongly and interest rates are hiked both in the western world and in India.

While you continue to like the Kotaks and the Berger Paints of the world, are you looking at expanding the number of stocks in your portfolio? Two things are playing out. One, flows into Marcellus have been very strong over the last 12 months. As the money that we are managing is basically moving towards the billion dollar mark, we are adding a few more stocks because there is only so much you can buy in a name and many of the names that we own we are already accounting for a substantial part ...

On a consolidated basis, Divis Laboratories reported 31.1% jump in net profit to Rs 470.62 crore on a 21.9% rise in net sales to Rs 1701.44 crore in Q3 FY21 over Q3 FY20. The company reported a forex gain of Rs 2.53 crore in the quarter ended December 2020 as against a forex gain of Rs 17.96 crore in the quarter ended December 2019. Profit before tax in Q3 December 2020 stood at Rs 642.08 crore, up by 31.8% from Rs 487.32 crore in Q3 December 2019. Current tax expenses during the quarter incre...

Post Market views - Feb 5, 2021 - Mr. Binod Modi, Head Strategy at Reliance Securities.